FDA approves first generic of drug used to treat severe hypoglycemia. [ press release ]. Silver Spring, MD: U.S. Food and Drug Administration; December 28, 2020.

Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid.. The FDA ...

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low ...

Amphastar Pharmaceuticals' generic glucagon for injection USP, 1 mg/vial, packaged in an emergency kit, is the first-ever FDA approval of a generic version of rDNA Glucagon.

According to IQVIA, the U.S. sales for Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar, 1 mg, were approximately $144 million, and the overall U.S. sales of brand products containing ...

The Food and Drug Administration last Monday approved the new drug, which comes in a 1-mg vial packaged in an emergency kit. Glucagon is a hormone that spurs the liver to quickly increase blood ...

The generic glucagon (Amphastar Pharmaceuticals Inc.) is packaged as a 1 mg vial emergency kit. In its approval, the FDA found the generic glucagon to be bioequivalent and therapeutically ...

(RTTNews) - Amphastar Pharmaceuticals, Inc. (AMPH) said the FDA has approved its Abbreviated New Drug Application for Glucagon for Injection Emergency Kit, 1 mg. Glucagon is indicated for the ...

In such cases, they may need to use an emergency glucagon kit. This involves administering medication that can help quickly raise a person’s blood sugar levels. Glucagon is typically available ...

Case contains one (1) glass vial of Glucagon, one (1) glass and plastic Hyporet syringe with diluting solution for Glucagon, and one (1) folded paper insert with Information for the User. A card with ...

(RTTNews) - The U.S. Food and Drug Administration approved the first generic drug to treat severe hypoglycaemia or dangerously low blood sugar levels, which could occur in patients with diabetes ...